Σύγκριση μεθόδων

	Μίνι Ψυχική Κατάσταση Εξέταση	Εξέταση Γνωστικών Λειτουργιών Addenbrooke (ACE)
Πεδίο	Νευροψυχολογία	Νευροψυχολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1975	2000
Δημιουργός	Marshall Folstein	Padasalai Mathuranath
Τύπος	Clinician-administered cognitive screening instrument	Clinician-administered comprehensive cognitive examination
Θεμελιώδης πηγή	Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189-198.	Mathuranath, P. S., Nestor, P. J., Berrios, G. E., Rakowicz, W., & Hodges, J. R. (2000). A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology, 55(11), 1613-1620.
Εναλλακτικές ονομασίες	MMSE, Folstein MMSE	ACE, ACE-R, ACE-III, Addenbrooke Cognitive Examination
Συναφείς	5	5
Σύνοψη	The Mini-Mental State Examination (MMSE) is a brief, 30-point screening instrument developed by Folstein, Folstein, and McHugh in 1975 to assess cognitive function in clinical settings. It is designed to detect cognitive impairment and monitor cognitive decline over time, particularly in older adults and patients with suspected dementia. The MMSE remains one of the most widely used cognitive screening tools in primary care, neurology, and geriatric medicine worldwide.	The Addenbrooke's Cognitive Examination (ACE) is a brief yet comprehensive clinician-administered cognitive battery designed to assess multiple cognitive domains and differentiate between types of dementia. Originally developed by Mathuranath and colleagues at Cambridge University in 2000, the ACE was created to address limitations of single-domain screening tools. The revised version (ACE-R, 2006) and further refined version (ACE-III, 2013) provide updated norms and improved sensitivity. The ACE-R and ACE-III are particularly valuable for distinguishing Alzheimer's disease from frontotemporal dementia.